156 related articles for article (PubMed ID: 25153376)
1. Bone morphogenetic protein antagonist gremlin-1 regulates colon cancer progression.
Karagiannis GS; Musrap N; Saraon P; Treacy A; Schaeffer DF; Kirsch R; Riddell RH; Diamandis EP
Biol Chem; 2015 Feb; 396(2):163-83. PubMed ID: 25153376
[TBL] [Abstract][Full Text] [Related]
2. Gremlin-1: An endogenous BMP antagonist induces epithelial-mesenchymal transition and interferes with redifferentiation in fetal RPE cells with repeated wounds.
Li D; Yuan D; Shen H; Mao X; Yuan S; Liu Q
Mol Vis; 2019; 25():625-635. PubMed ID: 31700227
[TBL] [Abstract][Full Text] [Related]
3. Enrichment map profiling of the cancer invasion front suggests regulation of colorectal cancer progression by the bone morphogenetic protein antagonist, gremlin-1.
Karagiannis GS; Berk A; Dimitromanolakis A; Diamandis EP
Mol Oncol; 2013 Aug; 7(4):826-39. PubMed ID: 23659962
[TBL] [Abstract][Full Text] [Related]
4. Cancer-associated fibroblast-derived Gremlin 1 promotes breast cancer progression.
Ren J; Smid M; Iaria J; Salvatori DCF; van Dam H; Zhu HJ; Martens JWM; Ten Dijke P
Breast Cancer Res; 2019 Sep; 21(1):109. PubMed ID: 31533776
[TBL] [Abstract][Full Text] [Related]
5. Gremlin-mediated decrease in bone morphogenetic protein signaling promotes aristolochic acid-induced epithelial-to-mesenchymal transition (EMT) in HK-2 cells.
Li Y; Wang Z; Wang S; Zhao J; Zhang J; Huang Y
Toxicology; 2012 Jul; 297(1-3):68-75. PubMed ID: 22525892
[TBL] [Abstract][Full Text] [Related]
6. Gremlin is a key pro-fibrogenic factor in chronic pancreatitis.
Staloch D; Gao X; Liu K; Xu M; Feng X; Aronson JF; Falzon M; Greeley GH; Rastellini C; Chao C; Hellmich MR; Cao Y; Ko TC
J Mol Med (Berl); 2015 Oct; 93(10):1085-1093. PubMed ID: 26141517
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of stromal GREM1 expression in colorectal cancer.
Jang BG; Kim HS; Chang WY; Bae JM; Oh HJ; Wen X; Jeong S; Cho NY; Kim WH; Kang GH
Hum Pathol; 2017 Apr; 62():56-65. PubMed ID: 28041973
[TBL] [Abstract][Full Text] [Related]
8. The Balance of Stromal BMP Signaling Mediated by GREM1 and ISLR Drives Colorectal Carcinogenesis.
Kobayashi H; Gieniec KA; Wright JA; Wang T; Asai N; Mizutani Y; Lida T; Ando R; Suzuki N; Lannagan TRM; Ng JQ; Hara A; Shiraki Y; Mii S; Ichinose M; Vrbanac L; Lawrence MJ; Sammour T; Uehara K; Davies G; Lisowski L; Alexander IE; Hayakawa Y; Butler LM; Zannettino ACW; Din MO; Hasty J; Burt AD; Leedham SJ; Rustgi AK; Mukherjee S; Wang TC; Enomoto A; Takahashi M; Worthley DL; Woods SL
Gastroenterology; 2021 Mar; 160(4):1224-1239.e30. PubMed ID: 33197448
[TBL] [Abstract][Full Text] [Related]
9. The role of gremlin, a BMP antagonist, and epithelial-to-mesenchymal transition in proliferative vitreoretinopathy.
Lee H; O'Meara SJ; O'Brien C; Kane R
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4291-9. PubMed ID: 17724219
[TBL] [Abstract][Full Text] [Related]
10. Gremlin: a novel mediator of epithelial mesenchymal transition and fibrosis in chronic allograft nephropathy.
Carvajal G; Droguett A; Burgos ME; Aros C; Ardiles L; Flores C; Carpio D; Ruiz-Ortega M; Egido J; Mezzano S
Transplant Proc; 2008 Apr; 40(3):734-9. PubMed ID: 18455002
[TBL] [Abstract][Full Text] [Related]
11. Expression of gremlin, a bone morphogenetic protein antagonist, in glomerular crescents of pauci-immune glomerulonephritis.
Mezzano S; Droguett A; Burgos ME; Aros C; Ardiles L; Flores C; Carpio D; Carvajal G; Ruiz-Ortega M; Egido J
Nephrol Dial Transplant; 2007 Jul; 22(7):1882-90. PubMed ID: 17403698
[TBL] [Abstract][Full Text] [Related]
12. Role of RUNX3 in bone morphogenetic protein signaling in colorectal cancer.
Lee CW; Ito K; Ito Y
Cancer Res; 2010 May; 70(10):4243-52. PubMed ID: 20442291
[TBL] [Abstract][Full Text] [Related]
13. Knockdown GREM1 suppresses cell growth, angiogenesis, and epithelial-mesenchymal transition in colon cancer.
Liu Y; Li Y; Hou R; Shu Z
J Cell Biochem; 2019 Apr; 120(4):5583-5596. PubMed ID: 30426548
[TBL] [Abstract][Full Text] [Related]
14. Effects of TGF-beta2, BMP-4, and gremlin in the trabecular meshwork: implications for glaucoma.
Wordinger RJ; Fleenor DL; Hellberg PE; Pang IH; Tovar TO; Zode GS; Fuller JA; Clark AF
Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1191-200. PubMed ID: 17325163
[TBL] [Abstract][Full Text] [Related]
15. Expression patterns of bone morphogenetic protein antagonists in colorectal cancer desmoplastic invasion fronts.
Karagiannis GS; Treacy A; Messenger D; Grin A; Kirsch R; Riddell RH; Diamandis EP
Mol Oncol; 2014 Oct; 8(7):1240-52. PubMed ID: 24812030
[TBL] [Abstract][Full Text] [Related]
16. Bone Morphogenetic Protein Pathway Antagonism by Grem1 Regulates Epithelial Cell Fate in Intestinal Regeneration.
Koppens MAJ; Davis H; Valbuena GN; Mulholland EJ; Nasreddin N; Colombe M; Antanaviciute A; Biswas S; Friedrich M; Lee L; ; Wang LM; Koelzer VH; East JE; Simmons A; Winton DJ; Leedham SJ
Gastroenterology; 2021 Jul; 161(1):239-254.e9. PubMed ID: 33819486
[TBL] [Abstract][Full Text] [Related]
17. Gremlin-1 Promotes Colorectal Cancer Cell Metastasis by Activating ATF6 and Inhibiting ATF4 Pathways.
Li R; Zhou H; Li M; Mai Q; Fu Z; Jiang Y; Li C; Gao Y; Fan Y; Wu K; Costa CD; Sheng X; He Y; Li N
Cells; 2022 Jul; 11(14):. PubMed ID: 35883579
[TBL] [Abstract][Full Text] [Related]
18. Bone morphogenetic protein-4 inhibitor gremlin is overexpressed in idiopathic pulmonary fibrosis.
Koli K; Myllärniemi M; Vuorinen K; Salmenkivi K; Ryynänen MJ; Kinnula VL; Keski-Oja J
Am J Pathol; 2006 Jul; 169(1):61-71. PubMed ID: 16816361
[TBL] [Abstract][Full Text] [Related]
19. Activation of AKT signaling promotes epithelial-mesenchymal transition and tumor growth in colorectal cancer cells.
Suman S; Kurisetty V; Das TP; Vadodkar A; Ramos G; Lakshmanaswamy R; Damodaran C
Mol Carcinog; 2014 Feb; 53 Suppl 1():E151-60. PubMed ID: 24000138
[TBL] [Abstract][Full Text] [Related]
20. Gremlin-1 Promotes Metastasis of Breast Cancer Cells by Activating STAT3-MMP13 Signaling Pathway.
Sung NJ; Kim NH; Surh YJ; Park SA
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33287358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
